Podiatrists in the US - Industry Research Report

Best Foot Forward: Revenue Will Likely Rise as More Healthcare Providers Stress the Importance of Preventive Care

COVID-19 brought a temporary setback for podiatrists' revenue, but telemedicine and government aid softened the negative impact on profit. Post-COVID-19, a rebound in sports participation, increased obesity rates and growth in the number of adults aged 65 and older brought feet and ankles back to the examining room. Increases in federal funding for Medicare, Medicaid and recreation expenditures supported payments for the medical services. Despite the losses experienced in 2020, industry-wide revenue has grown at an estimated CAGR of 2.3% to $7 billion over the five years to 2023, when revenue is expected to jump an estimated 5.1%.

This industry includes the operations of health practitioners who have the degree of DPM (Doctor of Podiatric Medicine) and are primarily engaged in the independent practice of podiatry. These practitioners diagnose and treat diseases and deformities of the foot and operate private or group practices in their own offices or in the facilities of other institutions, such as hospitals and other medical centers.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.